1-8 of 8
Ami B. Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A National Analysis of Overall Survival and Demographic Features

Victoria A. Vardell, Douglas J. Peters, Srinivas K. Tantravahi, Ami B. Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 1350–1352.
https://doi.org/10.1182/blood-2022-170734
Published: 2022
Journal Articles

Concerto (NCT04409639): A Phase 2 Trial of Cobimetinib in Newly Diagnosed and HMA-Treated CMML Patients with RAS Pathway Mutations

Ami B. Patel, Afaf Osman, Tony D. Pomicter, Srinivas K. Tantravahi, Michael W. Deininger
Journal: Blood
Blood (2022) 140 (Supplement 1): 4060–4061.
https://doi.org/10.1182/blood-2022-163570
Published: 2022
Journal Articles

Development of a Comprehensive Program for Evaluation of Hereditary Predisposition to Hematologic Malignancies

Jennie Vagher, Bryan D. Huber, Luke Maese, Archana M Agarwal, Afaf Osman, Ami B. Patel, Tsewang Tashi, Paul J Shami, Tibor Kovacsovics, Julie D. Asch, Charles J. Parker, Srinivas K. Tantravahi
Journal: Blood
Blood (2022) 140 (Supplement 1): 11468–11470.
https://doi.org/10.1182/blood-2022-170000
Published: 2022
Journal Articles

A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with Myelofibrosis Refractory or Intolerant to JAK Inhibitors

Srinivas K. Tantravahi, Soo Jin Kim, Divya Sundar, Ami B. Patel, Anthony D. Pomicter, Kenneth M. Boucher, Kamal Chamoun, Jatin Shah, Anton Rets, Tracy I. George, Josef T. Prchal, Michael W. Deininger
Journal: Blood
Blood (2021) 138 (Supplement 1): 143.
https://doi.org/10.1182/blood-2021-153940
Published: 2021
Journal Articles

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Ami B. Patel, Anca Franzini, Emilie Leroy, Soo Jin Kim, Anthony D. Pomicter, Lidvine Genet, Michael Xiao, Dongqing Yan, Jonathan M. Ahmann, Archana M. Agarwal, Phillip Clair, Juanah Addada, Jonathan Lambert, Matthew Salmon, Gerald J. Gleich, Nicholas C. P. Cross, Stefan N. Constantinescu, Thomas O’Hare, Josef T. Prchal, Michael W. Deininger
Journal: Blood
Blood (2019) 134 (26): 2388–2398.
https://doi.org/10.1182/blood.2019001385
Published: 2019
Includes: Supplemental data
Journal Articles

Combining Dasatinib and AC220 Reduces Stroma-Based pSTAT5Y694 in FLT3-ITD+ AML and Overcomes FLT3 TKI Resistance

Ami B. Patel, MD, Anthony D. Pomicter, MS, Dongqing Yan, Anna M. Eiring, PhD, Anca Franzini, PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2641.
https://doi.org/10.1182/blood-2018-99-117276
Published: 2018
Journal Articles

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Ami B. Patel, MD, Anca Franzini, PhD, Emilie Leroy, PhD, Dongqing Yan, Anna M. Eiring, PhD, Stefan N. Constantinescu, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4212.
https://doi.org/10.1182/blood.V130.Suppl_1.4212.4212
Published: 2017
Journal Articles

miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

Jared A. Wallace, Dominique A. Kagele, Anna M. Eiring, Carissa N. Kim, Ruozhen Hu, Marah C. Runtsch, Margaret Alexander, Thomas B. Huffaker, Soh-Hyun Lee, Ami B. Patel, Timothy L. Mosbruger, Warren P. Voth, Dinesh S. Rao, Rodney R. Miles, June L. Round, Michael W. Deininger, Ryan M. O’Connell
Journal: Blood
Blood (2017) 129 (23): 3074–3086.
https://doi.org/10.1182/blood-2016-09-740209
Published: 2017